Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Conditions: Prostate Cancer Interventions: Drug: Darolutamide; Drug: Darolutamide matched placebo; Radiation: Radiotherapy; Drug: Zoladex 3.6Mg Implant; Drug: Zoladex LA; Drug: Decapeptyl sustained release 22.5 mg; Drug: Decapeptyl sustained release 11.25 mg; Drug: Depo-Eligard 45 mg; Drug: Depo-Eligard 22.5 mg; Drug: Depo-Eligard 7.5 mg; Drug: Firmagon 120 MG Injection; Drug: Firmagon 80 MG Injection; Drug: Docetaxel Sponsors: Cancer Research Antwerp; Bayer; Veracyte, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
National Robotics-Assisted Radical Prostatectomy Database
Conditions: Database; Prostate Cancer; Robotic-assisted Radical Prostatectomy; Surgical Outcomes; Oncological Outcomes; Patient Reported Outcome Measures; Learning Curve Sponsors: Melbourne Health; Peter MacCallum Cancer Centre, Australia; Epworth Healthcare; St Vincent ' s Hospital; Austin Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision
Conditions: Prostate Cancer Interventions: Diagnostic Test: 3D multi-parametric ultrasound targeted biopsy pathway using PcaVision; Diagnostic Test: MRI targeted biopsy pathway Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Angiogenesis Analytics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process
Conditions: Prostate Cancer; Breast Cancer Interventions: Other: Remote monitoring PROs Sponsors: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.
Conditions: Prostate Cancer Interventions: Device: Use of Virtual Reality Assistance during prostate biopsies Sponsors: University Hospital, Geneva Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Conditions: Androgen Axis Suppression; Prostatectomy; Prostate Cancer Interventions: Drug: Apalutamide; Drug: Androgen Deprivation Therapy Sponsors: M.D. Anderson Cancer Center; Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
Conditions: Oligometastatic Prostate Carcinoma Sponsors: Istituto Oncologico Veneto IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Focal Therapy for Localized Prostate Cancer
Conditions: Prostate Cancer Interventions: Procedure: Focal Therapy Sponsors: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
Conditions: Prostate Cancer Interventions: Drug: Transdermal estrogen; Drug: Active Comparator: Androgen deprivation therapy; Behavioral: Resistance training Sponsors: Central Finland Hospital District; Tampere University; University of Jyvaskyla; Tampere University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Prospective Registry of Patients Undergoing Focal Therapy for Localized Prostate Cancer
Conditions: Prostate Cancer Interventions: Procedure: Focal Therapy Sponsors: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Conditions: Metastatic Prostate Cancer Interventions: Biological: AZD0754 Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer
Conditions: Prostate Cancer Interventions: Device: Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation Sponsors: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Conditions: MRI Scan Interventions: Drug: MT218 injection Sponsors: Molecular Theranostics LLC; Emory University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
Conditions: Prostate Cancer Metastatic Interventions: Diagnostic Test: Blood draw for ctDNA and circulating tumor cell collection. Sponsors: Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors; Breast Cancer; Recurrent Ovarian Cancer; Prostate Cancer Interventions: Drug: VIO-01 Sponsors: Valerio Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
